POTEE

POTE ankyrin domain family member E · Q6S8J3 · POTEE on Sugi Atlas →

0 patent compounds predicted against POTEE, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to POTEE by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Weight Loss Study: Genetics and Response to Naltrexone/Bupropion PHASE4RECRUITING
Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation PHASE2/PHASE3UNKNOWN
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome nanRECRUITING
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Idiopathic Dilated Cardiomyopathy nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH) nanRECRUITING
A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation nanRECRUITING
PCD New Gene Discovery nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia nanRECRUITING
Familial Intracranial Aneurysm Study II nanCOMPLETED
Natural History of Apparent Mineralocorticoid Excess Syndrome nanCOMPLETED
Identification of a New Gene Involved in Hereditary Lipodystrophy nanCOMPLETED
Genetic Analysis of Familial Hypertrophic Cardiomyopathy nanCOMPLETED
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Genetics and Psychopathology in the 22q11 Deletion Syndrome nanUNKNOWN
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA nanRECRUITING
Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES) nanCOMPLETED
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants nanRECRUITING
Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank nanCOMPLETED
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a POTEE binder may also engage these)

ProteinNameSimilarity
P0CG38 1.000 P0CG38 →
A5A3E0 1.000 A5A3E0 →
P0CG39 1.000 P0CG39 →
A6NI47 0.983 A6NI47 →
Q9SSE9 0.981 Q9SSE9 →
Q8RXK2 0.980 Q8RXK2 →
Q9FYH1 0.980 Q9FYH1 →
A0A1L8G2K9 0.979 A0A1L8G2K9 →
P0DXB9 0.979 P0DXB9 →
F4JQ51 0.979 F4JQ51 →
B4R4H1 0.979 B4R4H1 →
Q8N2N9 0.979 Q8N2N9 →
B5DUH6 0.978 B5DUH6 →
Q9BXX2 0.978 Q9BXX2 →
Q6PHG8 0.978 Q6PHG8 →
Q9SZ67 0.977 Q9SZ67 →
Q9M0T3 0.977 Q9M0T3 →
F4IJK6 0.977 F4IJK6 →
Q6S5H5 0.977 Q6S5H5 →
F4JZW1 0.977 F4JZW1 →
F4JCB2 0.977 F4JCB2 →
Q86YR6 0.977 Q86YR6 →
Q6S545 0.977 Q6S545 →
H3BUK9 0.977 H3BUK9 →
A0A0A6YYL3 0.977 A0A0A6YYL3 →
Q9BXX3 0.976 Q9BXX3 →
Q08ER8 0.976 Q08ER8 →
Q8N9K5 0.976 Q8N9K5 →
Q8GYD9 0.976 Q8GYD9 →
Q95J96 0.976 Q95J96 →